Skip to main content

(HS Johnson 096251 2022) Evidence-Based Therapy Practices in Psilocybin-Assisted Interventions

Tracking # 20-942894

$99999.00

4.5 (2 ratings)
Learn more
Educator PESI, INC.
CE Broker Reporting Reported automatically
Method Home Study

Course overview

This recording will explore modern approaches to psychotherapy using the classic psychedelic compound psilocybin. This includes a variety of disorders including substance use disorders, affective, and anxiety disorders. Methods for assuring safety as well as maximizing efficacy will be reviewed.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling

Certified Master Social Worker

1h General

Licensed Clinical Social Worker

1h General

Licensed Marriage and Family Therapist

1h General

Licensed Mental Health Counselor

1h General

Florida Board of Nursing

Advanced Practice Registered Nurse

1h General

Licensed Practical Nurse

1h General

Registered Nurse

1h General

Florida Board of Psychology

Limited License Psychologist

1h General

Psychologist

1h General

Ohio Counselor, Social Worker and Marriage and Family Therapist Board

Licensed Independent Marriage and Family Therapist

1h Continuing Education for Marriage and Family Therapists

Licensed Independent Social Worker

1h Continuing Education for Social Workers

Licensed Professional Clinical Counselor

1h Continuing Education for Counselors

Licensed Professional Counselor

1h Continuing Education for Counselors

Licensed Social Worker

1h Continuing Education for Social Workers

Marriage and Family Therapist

1h Continuing Education for Marriage and Family Therapists

Registered Social Worker Assistant

1h Continuing Education for Social Workers

Disclosure statements

Speaker Disclosures:

Financial: Dr. Matthew Johnson has an employment relationship with Johns Hopkins University School of Medicine and receives a consulting fee from Field Trip Psychedelics Inc, AJNA Labs LLC, AWAKN Life Sciences Inc, Beckley Psychedelic Ltd, Entheogen Biomedical Corp, and Otsuka Pharmaceutical Development & Commercialization Inc. He receives grants from NIH/NIDA, Mydecine Innovations Group Inc., Heffter Research Institute, Steven and Alexandra Cohen Foundation, Tim Ferriss Collaborative, Usona Institute, Realm of Caring Foundation, and Microdoz Therapy, Inc. Dr. Johnson receives a speaking honorarium from Psychotherapy Networker and PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.

Non-financial: Dr. Matthew Johnson is a member of the Society for Quantitative Analysis of Behavior, the American Psychological Association, the Association for Behavior Analysis International, the College on Problems of Drug Dependence, the International Study Group Investigating Drugs as Reinforcers, and the International Society for Research on Psychedelics.

Learner Feedback